Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Aclidinium Bromide for Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-33)

ClinicalTrials.gov ID: NCT00891462

Public ClinicalTrials.gov record NCT00891462. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 6:12 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of Aclidinium Bromide at Two Dose Levels (200 μg Twice Daily, 400 μg Twice Daily) vs. Placebo When Administered to Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the efficacy (effectiveness) and safety of aclidinium bromide doses as compared to placebo in the treatment of moderate to severe chronic obstructive pulmonary disease. The study will be 16 weeks in duration; 2-week run-in period, 12-week double-blind treatment, and 2-week follow-up phone visit.

Study identification

NCT ID
NCT00891462
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
561 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2009 (Type not available)
Primary completion
Nov 2009 (Actual)
Completion
Nov 2009 (Actual)
Last update posted
Jan 6, 2017

2009

United States locations

U.S. sites
104
U.S. states
34
U.S. cities
93
Facility City State ZIP Site status
Forest Investigative Site Birmingham Alabama 35209 —
Forest Investigative Site Jasper Alabama 35501 —
Forest Investigative Site Mobile Alabama 18020 —
Forest Investigative Site Mesa Arizona 85210 —
Forest Investigative Site Phoenix Arizona 85006 —
Forest Investigative Site Phoenix Arizona 85023 —
Forest Investigative Site Anaheim California 92801 —
Forest Investigative Site Encinitas California 92024 —
Forest Investigative Site Fresno California 93726 —
Forest Investigative Site Fullerton California 92835 —
Forest Investigative Site Lakewood California 90712 —
Forest Investigative Site Orange California 92868 —
Forest Investigative Site Palo Alto California 94304 —
Forest Investigative Site Rancho Mirage California 92270 —
Forest Investigative Site Sacramento California 95831 —
Forest Investigative Site San Diego California 92103-8415 —
Forest Investigative Site San Diego California 92120 —
Forest Investigative Site Colorado Springs Colorado 80907 —
Forest Investigative Site Denver Colorado 80206 —
Forest Investigative Site Wheat Ridge Colorado 80033 —
Forest Investigative Site Waterbury Connecticut 06708 —
Forest Investigative Site Brandon Florida 33511 —
Forest Investigative Site Clearwater Florida 33765 —
Forest Investigative Site DeLand Florida 32720 —
Forest Investigative Site Fort Lauderdale Florida 33316 —
Forest Investigative Site Melbourne Florida 32901 —
Forest Investigative Site Melbourne Florida 32935 —
Forest Investigative Site Ormond Beach Florida 32174 —
Forest Investigative Site Panama City Florida 32405 —
Forest Investigative Site Pensacola Florida 32504 —
Forest Investigative Site Tamarac Florida 33321 —
Forest Investigative Site Tampa Florida 33603 —
Forest Investigative Site Tampa Florida 33613 —
Forest Investigative Site Austell Georgia 30106 —
Forest Investigative Site Blue Ridge Georgia 30513 —
Forest Investigative Site Duluth Georgia 30096 —
Forest Investigative Site Marietta Georgia 30060 —
Forest Investigative Site River Forest Illinois 60305 —
Forest Investigative Site Skokie Illinois 60076 —
Forest Investigative Site South Bend Indiana 46617 —
Forest Investigative Site Crescent Springs Kentucky 41017 —
Forest Investigative Site Lexington Kentucky 40504 —
Forest Investigative Site Lafayette Louisiana 70503 —
Forest Investigative Site Bangor Maine 04401 —
Forest Investigative Site Baltimore Maryland 21201 —
Forest Investigative Site Baltimore Maryland 21224 —
Forest Investigative Site Hagerstown Maryland 21740 —
Forest Investigative Site North Dartmouth Massachusetts 02747 —
Forest Investigative Site Livonia Michigan 48152 —
Forest Investigative Site Edina Minnesota 55435 —
Forest Investigative Site Minneapolis Minnesota 55402 —
Forest Investigative Site Minneapolis Minnesota 55407 —
Forest Investigative Site Florissant Missouri 63033 —
Forest Investigative Site Saint Charles Missouri 63301 —
Forest Investigative Site Billings Montana 59102 —
Forest Investigative Site Butte Montana 59701 —
Forest Investigative Site Papillion Nebraska 68046 —
Forest Investigative Site Berlin New Jersey 08009 —
Forest Investigative Site Summit New Jersey 07901 —
Forest Investigative Site Brooklyn New York 11234 —
Forest Investigative Site Buffalo New York 14215 —
Forest Investigative Site Great Neck New York 11023 —
Forest Investigative Site Ithaca New York 14580 —
Forest Investigative Site New Hyde Park New York 11040 —
Forest Investigative Site New York New York 10004 —
Forest Investigative Site New York New York 10016 —
Forest Investigative Site Asheville North Carolina 28801 —
Forest Investigative Site Charlotte North Carolina 28207 —
Forest Investigative Site Raleigh North Carolina 27607 —
Forest Investigative Site Canton Ohio 44718 —
Forest Investigative Site Cincinnati Ohio 45227 —
Forest Investigative Site Cincinnati Ohio 45231 —
Forest Investigative Site Cincinnati Ohio 45242 —
Forest Investigative Site Columbus Ohio 43215 —
Forest Investigative Site Toledo Ohio 43606 —
Forest Investigative Site Oklahoma City Oklahoma 73120 —
Forest Investigative Site Medford Oregon 97504 —
Forest Investigative Site Portland Oregon 97213 —
Forest Investigative Site Bethlehem Pennsylvania 18020 —
Forest Investigative Site Erie Pennsylvania 16506 —
Forest Investigative Site Hershey Pennsylvania 17033 —
Forest Investigative Site Pittsburgh Pennsylvania 15243 —
Forest Investigative Site Upland Pennsylvania 19013 —
Forest Investigative Site East Providence Rhode Island 02914 —
Forest Investigative Site Johnston Rhode Island 02919 —
Forest Investigative Site Charleston South Carolina 29406 —
Forest Investigative Site Greenville South Carolina 29615 —
Forest Investigative Site Greer South Carolina 29651 —
Forest Investigative Site Spartanburg South Carolina 29303 —
Forest Investigative Site Nashville Tennessee 37232-2650 —
Forest Investigative Site Dallas Texas 75231 —
Forest Investigative Site Dallas Texas 75246 —
Forest Investigative Site Fort Worth Texas 76104 —
Forest Investigative Site Houston Texas 77024 —
Forest Investigative Site San Antonio Texas 78229 —
Forest Investigative Site Tyler Texas 75708 —
Forest Investigative Site Waco Texas 76712 —
Forest Investigative Site Midvale Utah 84047 —
Forest Investigative Site Richmond Virginia 23225 —
Forest Investigative Site Richmond Virginia 23249 —
Forest Investigative Site Bellingham Washington 98225 —
Forest Investigative Site Spokane Washington 99204 —
Forest Investigative Site Tacoma Washington 98405 —
Forest Investigative Site Milwaukee Wisconsin 53209 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00891462, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 6, 2017 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00891462 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →